Direct oral anticoagulants for the treatment of cancer-associated thrombosis
Cancer-associated venous thromboembolism (VTE) is known to impact up to one-fifth of patients with cancer. The...
Most Read
ASCO Guideline Update on VTE Prophylaxis and Treatment in Patients with Cancer
The American Society of Clinical Oncology (ASCO) has been developing guidelines on cancer-associated thrombosis (CAT)...
Thrombocytopenia and management of anticoagulation in the patient with thrombosis and cancer
Cancer-associated thrombosis (CAT) presents a unique and multifaceted challenge in clinical practice, particularly in...
An Overview of VTE Prevention and Management in Gynecological Cancer Care
As with cancers in general, gynecological cancers also exhibit a clear and increasingly significant association with...
Cancer-associated thrombosis in children
Venous thromboembolism (VTE) is one of the leading causes of death in adult cancer patients and represents a challenge...
Developmental hemostasis and its relevance to pediatric thrombosis
The coagulation system of neonates and children evolves with age, as evidenced by marked physiological differences in...
10th ICTHIC RESCHEDULED: 30 April – 2 May 2021
The COVID-19 pandemic is improving globally, and the situation is gradually returning back to normal. Nevertheless, to...
Is apixaban safe for primary VTE prevention in patients with gastrointestinal cancers? A summary of a post-hoc analysis of the AVERT trial
Patients with cancer and a Khorana score ≥2 have an estimated risk of symptomatic venous thromboembolism (VTE) of...
Disseminated Intravascular coagulation in solid and hematological cancers
Introduction There is a clear relationship between malignancy and deranged coagulation. Patients with cancer are at...
D-dimer and its role in venous thromboembolism
D-dimer is a marker of coagulation activation and thrombotic activity. The analysis of D-dimer levels is used to...